BE905332A - Nouvelles substances antibiotiques et antitumorales, procede pour leur obtention et isolation; compositions pharmaceutiques les contenant. - Google Patents

Nouvelles substances antibiotiques et antitumorales, procede pour leur obtention et isolation; compositions pharmaceutiques les contenant.

Info

Publication number
BE905332A
BE905332A BE0/217084A BE217084A BE905332A BE 905332 A BE905332 A BE 905332A BE 0/217084 A BE0/217084 A BE 0/217084A BE 217084 A BE217084 A BE 217084A BE 905332 A BE905332 A BE 905332A
Authority
BE
Belgium
Prior art keywords
pharmaceutical compositions
insulation
obtaining
same
compositions containing
Prior art date
Application number
BE0/217084A
Other languages
English (en)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of BE905332A publication Critical patent/BE905332A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/03—Actinomadura

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

D'après le procédé les substances BBM-1675C et BBM-1675D ont été obtenues par hydrolyse chimique sélective des composants biologiquement actifs BBM-1675A1 (espéramicine A1) ou BBM-1675A2 (espéramicine A2). Le procédé permet notamment la réalisation de compositions pharmaceutiques antimicrobiennes et antitumorales.
BE0/217084A 1985-08-27 1986-08-26 Nouvelles substances antibiotiques et antitumorales, procede pour leur obtention et isolation; compositions pharmaceutiques les contenant. BE905332A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77033585A 1985-08-27 1985-08-27

Publications (1)

Publication Number Publication Date
BE905332A true BE905332A (fr) 1987-02-26

Family

ID=25088206

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/217084A BE905332A (fr) 1985-08-27 1986-08-26 Nouvelles substances antibiotiques et antitumorales, procede pour leur obtention et isolation; compositions pharmaceutiques les contenant.

Country Status (26)

Country Link
JP (2) JPH0733393B2 (fr)
KR (1) KR920010226B1 (fr)
AT (1) AT392971B (fr)
AU (1) AU604464B2 (fr)
BE (1) BE905332A (fr)
CA (1) CA1307256C (fr)
CH (1) CH668598A5 (fr)
CY (1) CY1676A (fr)
DE (1) DE3629052C2 (fr)
DK (1) DK170671B1 (fr)
ES (1) ES2002728A6 (fr)
FI (1) FI83422C (fr)
FR (1) FR2586686B1 (fr)
GB (1) GB2179649A (fr)
GR (1) GR862160B (fr)
HK (1) HK793A (fr)
HU (1) HU197915B (fr)
IE (1) IE59204B1 (fr)
IL (1) IL79519A0 (fr)
IT (1) IT1229176B (fr)
LU (1) LU86562A1 (fr)
NL (1) NL8602165A (fr)
PT (1) PT83261B (fr)
SE (2) SE469632B (fr)
SG (1) SG109692G (fr)
ZA (1) ZA865796B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2177518T3 (es) * 1987-01-30 2002-12-16 American Cyanamid Co Derivados dihidro de los antibioticos ll-e33288.
US4916065A (en) * 1988-06-10 1990-04-10 Bristol-Myers Company BU-3420T Antitumor antibiotic
US5028536A (en) * 1989-03-15 1991-07-02 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41339
US5086045A (en) * 1989-03-15 1992-02-04 Bristol-Myers Squibb Company Antitumor antibiotic
CA2027601A1 (fr) * 1989-11-06 1991-05-07 Koko Sugawara Antibiotique antitumeur bu-3983t
CA2039789A1 (fr) * 1990-04-27 1991-10-28 Samuel J. Danishefsky Calicheamicinone, derives et analogues, et methodes de fabrication
US5116845A (en) * 1990-05-04 1992-05-26 Bristol-Myers Company BU-3420T antitumor antibiotic
US5264586A (en) * 1991-07-17 1993-11-23 The Scripps Research Institute Analogs of calicheamicin gamma1I, method of making and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3148023A1 (de) * 1981-12-04 1983-06-09 Rudolf Dipl.-Ing. 8901 Oberottmarshausen Fischer Heizungskessel fuer heisse rauchgase
US4578271A (en) * 1982-05-24 1986-03-25 Fujisawa Pharmaceutical Co., Ltd. Biologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositions
NZ208013A (en) * 1983-05-16 1987-07-31 Bristol Myers Co Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora
JPS606194A (ja) * 1983-06-23 1985-01-12 Meiji Seika Kaisha Ltd 新規抗生物質ｓｆ−２２８８及びその製造法
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production

Also Published As

Publication number Publication date
DK406086A (da) 1987-02-28
IT8621527A0 (it) 1986-08-26
IL79519A0 (en) 1986-10-31
GB2179649B (fr) 1989-10-25
ZA865796B (en) 1987-04-29
SE469632B (sv) 1993-08-09
DK170671B1 (da) 1995-11-27
ATA231786A (de) 1990-12-15
IE862280L (en) 1987-02-27
IT1229176B (it) 1991-07-23
GR862160B (en) 1986-12-31
FI83422C (fi) 1991-07-10
JPH0733393B2 (ja) 1995-04-12
GB2179649A (en) 1987-03-11
KR870002269A (ko) 1987-03-30
SE8603597D0 (sv) 1986-08-26
FI83422B (fi) 1991-03-28
HUT44035A (en) 1988-01-28
SE9200428D0 (sv) 1992-02-13
ES2002728A6 (es) 1988-10-01
GB8620118D0 (en) 1986-10-01
AT392971B (de) 1991-07-25
IE59204B1 (en) 1994-01-26
HU197915B (en) 1989-06-28
NL8602165A (nl) 1987-03-16
FI863405A (fi) 1987-02-28
DE3629052A1 (de) 1987-05-07
LU86562A1 (fr) 1987-03-06
SG109692G (en) 1992-12-24
PT83261A (en) 1986-09-01
DE3629052C2 (de) 1995-09-28
DK406086D0 (da) 1986-08-26
CA1307256C (fr) 1992-09-08
AU604464B2 (en) 1990-12-20
AU6175186A (en) 1987-03-05
FI863405A0 (fi) 1986-08-22
FR2586686B1 (fr) 1990-02-02
JPH07233186A (ja) 1995-09-05
CH668598A5 (de) 1989-01-13
PT83261B (pt) 1989-05-12
JPS62116589A (ja) 1987-05-28
SE9200428L (sv) 1993-08-14
CY1676A (en) 1993-10-10
SE8603597L (sv) 1987-02-28
FR2586686A1 (fr) 1987-03-06
HK793A (en) 1993-01-15
KR920010226B1 (ko) 1992-11-21

Similar Documents

Publication Publication Date Title
FR2567131B1 (fr) Nouveaux derives de ganglioside, procede pour leur obtention et composition pharmaceutique les contenant
BE880584A (fr) Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant
OA07103A (fr) Nouvelles 1,2-diaminocyclobutène-3,4-diones, leur procédé de préparation et composition pharmaceutique les contenant.
BE889683A (fr) Nouveaux oligomeres tensio-actifs, leur procede de preparation et les compositions les contenant
FR2518095B1 (fr) Nouveaux l-oxa-, thia- et aza-spirocyclo-benzene-acetamides et benzamides, leur procede de preparation et composition pharmaceutique les contenant
FR2495154B1 (fr) 5'-aminoalkyl-4', 4, 8-trialkylpsoralenes, leur procede de production et composition pharmaceutique les contenant
MA21241A1 (fr) Procede de production de plants greffes de vegetaux ligneux pour l'obtention de plants, notamment de vigne, et plants obtenus.
OA07354A (fr) Nouveaux dérivés de céphalosporine, leur procédé de production et composition pharmaceutique les contenant.
HUT45021A (en) Process for production of insecticides and acaricides containing pirasoline-derivatives as active substance and process for production of the active substances
OA07172A (fr) Nouvelles thiazolidinediones, leur procédé de production et préparation pharmaceutique les contenant.
IE811513L (en) Benzisoselenazolones
BE905332A (fr) Nouvelles substances antibiotiques et antitumorales, procede pour leur obtention et isolation; compositions pharmaceutiques les contenant.
FR2433527A1 (fr) Nouveaux derives de type pyrimidinone, procede pour leur preparation et composition pharmaceutique les contenant
FR2434154A1 (fr) Nouveaux derives d'imidazole, utiles notamment comme anticonvulsivants, et leur procede de preparation
FR2490493B1 (fr) Composition pharmaceutique ou alimentaire contenant de l'a -cetoglutarate de pyridoxine, procede pour sa preparation
BE892552A (fr) Nouveaux amido-aminoacides, compositions pharmaceutiques les contenant et procede de preparation de ces amido-aminoacides
BE878230A (fr) Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant
FR2594847B1 (fr) Procede de preparation de polypeptides biologiquement actifs, polypeptides obtenus et compositions les contenant
OA07585A (fr) Nouveaux composés hétérocycliques, leur procédé de préparation et composition pharmaceutique les contenant.
OA07390A (fr) Nouveaux dérivés de carbapenem, compositions pharmaceutiques les contenant, composés intermédiaires pour leur préparation, et leurs procédés de production.
FR2568892B1 (fr) Nouvel antibiotique sandramycine, procede de preparation de celui-ci, culture biologiquement pure du micro-organisme nocardioides sp, atcc no 39419, et composition pharmaceutique contenant la sandramycine
FR2567520B1 (fr) Nouvelles phenyl-naphthyridines, leur procede de preparation, medicaments les contenant, notamment anti-ulceres
OA07513A (fr) Nouveaux dérivés d'acides (di) thiophosphoriques et-phospohoniques, procédé pour les préparer, produits en contenant et leur application en phytiatrie.
FR2558835B1 (fr) Derives d'hydantoine, leur procede de production et medicament les contenant
OA07171A (fr) Spirothiazolidineone, son procédé de préparation et préparation pharmaceutique la contenant.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BRISTOL-MYERS CY

Effective date: 19960831